The Journal — Issue 01

Why GLP-1 Users Lose Muscle — And What Actually Helps

The weight comes off. So does something else.

Most people on Ozempic, Wegovy, or Mounjaro don't expect to feel worse in some ways while feeling better in others. But a pattern keeps showing up in clinics and in the research: significant muscle loss alongside the fat loss, and a cluster of symptoms — fatigue, hair thinning, brain fog, muscle weakness — that the prescription leaflet doesn't quite prepare you for.

This isn't a failure of the medication. It's a consequence of how it works.

What GLP-1 medications actually do

GLP-1 receptor agonists work primarily by suppressing appetite. They slow gastric emptying, reduce hunger signals, and make food less interesting. For people who have struggled with appetite regulation for years, this can feel like a genuine relief.

But the body doesn't distinguish cleanly between fat mass and lean mass when it's in a sustained caloric deficit. Research published in the New England Journal of Medicine tracking semaglutide users found that roughly 39% of total weight lost came from lean mass — muscle, bone, and organ tissue — rather than fat. In some studies, that figure is higher.

For context: typical caloric restriction without medication produces lean mass loss of around 20–25% of total weight lost. GLP-1 medications, because they create deeper and more sustained deficits, can accelerate this.

Why this matters more than the scale suggests

Muscle isn't just aesthetic. It's metabolically active tissue that burns calories at rest, supports insulin sensitivity, protects joints, and maintains the structural integrity of your body as you age. Losing it accelerates the very metabolic slowdown that makes weight regain so common after any kind of dieting.

There's also the hair. Hair shedding — clinically called telogen effluvium — is one of the most commonly reported side effects among GLP-1 users, and it's underreported in formal trial data because it tends to appear three to five months into treatment, outside the window most trials are actively tracking. The mechanism is well understood: significant caloric restriction reduces the nutrients available for non-essential biological processes, and hair growth is one of the first things the body deprioritizes.

Biotin at adequate doses (5,000mcg, not the 30mcg in most standard multivitamins), folate, and vitamin D3 are the three nutrients most directly implicated in keratin infrastructure and hair follicle cycling. GLP-1 users consistently show deficiency in all three, partly because reduced food intake means reduced micronutrient intake across the board.

What the research supports

Creatine monohydrate is the most studied supplement in sports science, with over 500 peer-reviewed trials. At 3–5 grams per day, it reliably supports lean mass preservation during caloric restriction by maintaining phosphocreatine stores in muscle tissue — the primary fuel source for short, intense muscular contractions. It doesn't build muscle on its own. It preserves what's there when the conditions for muscle loss are present. GLP-1 therapy is precisely those conditions.

Berberine is more interesting and less understood. It's an alkaloid found in several plants that activates AMPK — adenosine monophosphate-activated protein kinase — the same enzyme pathway that GLP-1 medications target. Human trials have shown meaningful effects on fasting glucose, insulin sensitivity, and lipid profiles. It doesn't replace GLP-1 therapy, and it's not trying to. What it does is work on the same metabolic pathway through a different mechanism, which may compound the medication's effects rather than duplicate them.

The evidence base for berberine is smaller than for creatine and the studies are less rigorous. Anyone telling you it's a miracle compound is overselling it. Anyone dismissing it hasn't read the trials carefully.

What doesn't help

Most GLP-1 supplement products on the market are collections of generic multivitamin ingredients with GLP-1 branding applied after the fact. They weren't formulated with the specific deficiency profile of GLP-1 users in mind. They're capitalizing on a trend, not responding to a physiological reality.

The other thing that doesn't help is ignoring the problem. Muscle loss during GLP-1 therapy is real, documented, and addressable. It requires intentional resistance training, adequate protein intake (harder when appetite is suppressed), and targeted supplementation for the specific nutrients being depleted. None of this is complicated. Most of it isn't being told to patients at the point of prescription.

A note on what this is

This journal exists to write about GLP-1 science accurately — including when the evidence is uncertain, when studies conflict, and when something we believe turns out to be wrong. We sell supplements. We also think you should understand exactly what those supplements do and don't do before you buy them.

If you're on a GLP-1 medication and experiencing muscle loss, hair thinning, or fatigue, the right first conversation is with your prescribing physician. What we can offer is context.

— The Semante Team